Abstract
Gap junction channel selectivity, open probability, and recruitment are properties that affect the transit of solutes from cell to cell. Selectivity is the property of an open channel that acts as a discriminator, allowing the passage of specific solutes while denying transit to others. Open probability is another parameter that can affect the efficiency of cell to cell transit. Channel recruitment is another facilitating mechanism able to affect transit. Rapid alterations in any of these properties suggests that dynamic effects are possible for gap junction channel mediated cell to cell coupling. Suspect modulators presumably capable of effecting dynamic change would be the kinases. The properties of gap junction channels in the context of selectivity, open probability and recruitment are discussed here along with the ability of kinases to affect them. These processes and their regulation are also targets for regulating cell-to-cell communication through therapeutics. Clearly these same properties are ones that disease states might also opportunistically alter to affect physiological processes.
Current Drug Targets
Title: Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?
Volume: 3 Issue: 6
Author(s): Peter R. Brink
Affiliation:
Abstract: Gap junction channel selectivity, open probability, and recruitment are properties that affect the transit of solutes from cell to cell. Selectivity is the property of an open channel that acts as a discriminator, allowing the passage of specific solutes while denying transit to others. Open probability is another parameter that can affect the efficiency of cell to cell transit. Channel recruitment is another facilitating mechanism able to affect transit. Rapid alterations in any of these properties suggests that dynamic effects are possible for gap junction channel mediated cell to cell coupling. Suspect modulators presumably capable of effecting dynamic change would be the kinases. The properties of gap junction channels in the context of selectivity, open probability and recruitment are discussed here along with the ability of kinases to affect them. These processes and their regulation are also targets for regulating cell-to-cell communication through therapeutics. Clearly these same properties are ones that disease states might also opportunistically alter to affect physiological processes.
Export Options
About this article
Cite this article as:
Peter R. Brink , Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?, Current Drug Targets 2002; 3 (6) . https://dx.doi.org/10.2174/1389450023347326
DOI https://dx.doi.org/10.2174/1389450023347326 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Amyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis
Current Alzheimer Research Colloidal Supramolecular Aggregates for Therapeutic Application in Neuromedicine
Current Medicinal Chemistry Prion Protein Misfolding
Current Molecular Medicine Dimerization and Ion Binding Properties of S100P Protein
Protein & Peptide Letters Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation
Current Molecular Medicine Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication
Anti-Cancer Agents in Medicinal Chemistry Neurotrophic Effects of the Peptide NAP: A Novel Neuroprotective Drug Candidate
Current Alzheimer Research Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
CNS & Neurological Disorders - Drug Targets Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!
Current Cardiology Reviews Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus
Current Pharmaceutical Design Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders
Current Drug Metabolism Effects of Amine Oxidases in Allergic and Histamine-Mediated Conditions
Recent Patents on Inflammation & Allergy Drug Discovery Effect of Antioxidants on Heavy Metals Induced Conformational Alteration of Cytochrome C and Myoglobin
Protein & Peptide Letters Micro-RNAs, Exercise and Cellular Plasticity in Humans: The Impact of Dietary Factors and Hypoxia
MicroRNA Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Current Neuropharmacology Molecular Structure of Ionotropic Glutamate Receptors
Current Medicinal Chemistry Vitamins B1, B2, B3 and B9 – Occurrence, Biosynthesis Pathways and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Exploring the Role of Stem Cell Therapy in Treating Neurodegenerative Diseases: Challenges and Current Perspectives
Current Stem Cell Research & Therapy